Cargando…

2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic

BACKGROUND: The pattern of hepatitis C virus (HCV) transmission routes in sub-Saharan Africa (SSA) has not been previously well characterized. A recent meta-analysis reported a general population HCV prevalence of 5.4% and HIV co-infection prevalence of 3.6% in SSA, with considerable regional variat...

Descripción completa

Detalles Bibliográficos
Autores principales: Akyar, Eda, Mora, Nallely, Luke, Amy, Layden, Jennifer, Phillips, Richard, Agyarko-Poku, Thomas, Owusu, Dorcas, A-Siaw, Helena, Nahass, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254271/
http://dx.doi.org/10.1093/ofid/ofy210.1856
_version_ 1783373684689338368
author Akyar, Eda
Mora, Nallely
Luke, Amy
Layden, Jennifer
Phillips, Richard
Agyarko-Poku, Thomas
Owusu, Dorcas
A-Siaw, Helena
Nahass, Ronald
author_facet Akyar, Eda
Mora, Nallely
Luke, Amy
Layden, Jennifer
Phillips, Richard
Agyarko-Poku, Thomas
Owusu, Dorcas
A-Siaw, Helena
Nahass, Ronald
author_sort Akyar, Eda
collection PubMed
description BACKGROUND: The pattern of hepatitis C virus (HCV) transmission routes in sub-Saharan Africa (SSA) has not been previously well characterized. A recent meta-analysis reported a general population HCV prevalence of 5.4% and HIV co-infection prevalence of 3.6% in SSA, with considerable regional variation. METHODS: A cross-sectional study was performed in Kumasi, Ghana. Subjects were recruited from patients attending an STI clinic at a government-supported health center. Subjects completed a survey emphasizing known risk factors for HCV, including sexual behaviors, to capture potential routes of exposure. Surveys were administered in Twi, the local language, with the assistance of trained interpreters. Blood samples were collected and tested for HCV antibodies using DiaSpot Anti-HCV Rapid Screen Tests (USA). Data were analyzed using univariate analysis and logistic regression using SAS 9.4. RESULTS: Of the total 312 subjects, 15 were HCV positive (prevalence 4.8%). The HIV-HCV co-infection prevalence was 5.5%. After adjusting for age and sex, statistically significant associated risk factors for HCV infection (P < 0.05) include no/low level of education vs. tertiary (OR 5.0), northern region of birth vs. central region (OR 7.3), and traditional body scarring (OR 4.1). Rough sexual practices, ie dry sex, sores, were also explored and were associated with HCV infection (P = 0.02). Post-hoc stratified analysis of HIV-infected individuals (n = 201) was performed to identify risk factors among those with HCV co-infection. Significant risk factors (P < 0.05) in this sub-population include northern region of origin (OR 12.4) and traditional scars or marks (OR 4.6). CONCLUSION: Two risk factors for HCV infection, ie region of birth and traditional scarring, were significant in both the total clinic population and HIV co-infected individuals suggesting cultural practices are contributing to an increased risk of infection. Among HCV positive individuals, rough sexual practices were significant risk factors; whereas, IV-drug abuse was not. While HCV treatment exists, it is not currently available in West Africa; therefore, it is critical to identify risk factors to best target education programs and screening of populations to limit disease spread. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254271
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62542712018-11-28 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic Akyar, Eda Mora, Nallely Luke, Amy Layden, Jennifer Phillips, Richard Agyarko-Poku, Thomas Owusu, Dorcas A-Siaw, Helena Nahass, Ronald Open Forum Infect Dis Abstracts BACKGROUND: The pattern of hepatitis C virus (HCV) transmission routes in sub-Saharan Africa (SSA) has not been previously well characterized. A recent meta-analysis reported a general population HCV prevalence of 5.4% and HIV co-infection prevalence of 3.6% in SSA, with considerable regional variation. METHODS: A cross-sectional study was performed in Kumasi, Ghana. Subjects were recruited from patients attending an STI clinic at a government-supported health center. Subjects completed a survey emphasizing known risk factors for HCV, including sexual behaviors, to capture potential routes of exposure. Surveys were administered in Twi, the local language, with the assistance of trained interpreters. Blood samples were collected and tested for HCV antibodies using DiaSpot Anti-HCV Rapid Screen Tests (USA). Data were analyzed using univariate analysis and logistic regression using SAS 9.4. RESULTS: Of the total 312 subjects, 15 were HCV positive (prevalence 4.8%). The HIV-HCV co-infection prevalence was 5.5%. After adjusting for age and sex, statistically significant associated risk factors for HCV infection (P < 0.05) include no/low level of education vs. tertiary (OR 5.0), northern region of birth vs. central region (OR 7.3), and traditional body scarring (OR 4.1). Rough sexual practices, ie dry sex, sores, were also explored and were associated with HCV infection (P = 0.02). Post-hoc stratified analysis of HIV-infected individuals (n = 201) was performed to identify risk factors among those with HCV co-infection. Significant risk factors (P < 0.05) in this sub-population include northern region of origin (OR 12.4) and traditional scars or marks (OR 4.6). CONCLUSION: Two risk factors for HCV infection, ie region of birth and traditional scarring, were significant in both the total clinic population and HIV co-infected individuals suggesting cultural practices are contributing to an increased risk of infection. Among HCV positive individuals, rough sexual practices were significant risk factors; whereas, IV-drug abuse was not. While HCV treatment exists, it is not currently available in West Africa; therefore, it is critical to identify risk factors to best target education programs and screening of populations to limit disease spread. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254271/ http://dx.doi.org/10.1093/ofid/ofy210.1856 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Akyar, Eda
Mora, Nallely
Luke, Amy
Layden, Jennifer
Phillips, Richard
Agyarko-Poku, Thomas
Owusu, Dorcas
A-Siaw, Helena
Nahass, Ronald
2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
title 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
title_full 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
title_fullStr 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
title_full_unstemmed 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
title_short 2203. Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
title_sort 2203. risk factors for hepatitis c in western africa: an observational study in a sti clinic
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254271/
http://dx.doi.org/10.1093/ofid/ofy210.1856
work_keys_str_mv AT akyareda 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT moranallely 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT lukeamy 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT laydenjennifer 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT phillipsrichard 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT agyarkopokuthomas 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT owusudorcas 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT asiawhelena 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic
AT nahassronald 2203riskfactorsforhepatitiscinwesternafricaanobservationalstudyinasticlinic